Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-ΚB transcription factors

Human Molecular Genetics

Volumn 11, Issue 11, 2002, Pages 1281-1289

  Van Heel, David A ^a   Udalova, Irina A ^a   De Silva, Arjuna P ^b   McGovern, Dermot P ^a   Kinouchi, Yoshitaka ^c   Hull, Jeremy ^b   Lench, Nicholas J ^d   Cardon, Lon R ^a   Carey, Alisoun H ^d   Jewell, Derek P ^b   Kwiatkowski, Dominic ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Oxagen Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; OCTAMER TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; COLON CROHN DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENTERITIS; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HOMOZYGOTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RECESSIVE INHERITANCE; ULCERATIVE COLITIS;

ANIMALS; CASE-CONTROL STUDIES; CERCOPITHECUS AETHIOPS; COS CELLS; GENES, REPORTER; HOMOZYGOTE; HUMANS; INFLAMMATORY BOWEL DISEASES; NF-KAPPA B; ORGANIC CATION TRANSPORTER 1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18444395237     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Inflammatory bowel disease: Epidemiology and management in an English general practice population
2. Linkage of Crohn's disease to the major histocompatibility region is detected by multiple non-parametric analyses
3. Linkage of inflammatory bowel disease to human chromosome 6p
4. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
5. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3)
6. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR
7. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation
8. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease
9. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Cronh's disease: A European multicenter trial
10. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies
11. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
12. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
13. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
14. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp
15. Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes
16. Monocyte/macrophage activation by normal bacteria and bacterial products: Implications for altered epithelial function in Crohn's disease
17. Activation of nuclear factor kappa B inflammatory bowel disease
18. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine
19. Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line
20. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide
21. The core promoter region of the tumor necrosis factor alpha gene confers phorbol ester responsiveness to upstream transcriptional activators
22. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region
23. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
24. Genetic influence on cytokine production and fatal meningococcal disease
25. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene
26. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP
27. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors
28. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1
29. Functional interaction between Oct-1 and retinoid X receptor
30. Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics
31. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
32. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
33. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene
34. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: A case-control study
35. Association study designs for complex disease
36. Independent contributions of HLA-DRB1 and TNFα promoter polymorphisms to the susceptibility of Crohn's disease
37. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease
38. Inflammatory bowel disease in Japan: Studies of epidemiology and etiopathogenesis
39. Crohn's disease in Japan: Diagnostic criteria and epidemiology
40. Incidence and prevalence of inflammatory bowel disease in Japan: Nationwide epidemiological survey during the year 1991
41. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter
42. A common functional polymorphism (C→A substitution at position - 863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha
43. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter
44. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals
45. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese
46. Tumor necrosis factor: Biology and therapeutic inhibitors
47. High-resolution haplotype structure in the human genome
48. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex
49. Linkage disequilibrium in the human genome
50. Classification of inflammatory bowel disease
51. General score tests for associations of genetic markers with disease using cases and their parents
52. Unbiased application of the transmission/disequilibrium test to multilocus haplotypes
53. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
54. Conserved kappa B element located downstream of the tumor necrosis factor alpha gene: Distinct NF-kappa B binding pattern and enhancer activity in LPS activated murine macrophages
55. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
56. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome
57. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes